Health Industry

Latest KFF Health News Stories

Decades of National Suicide Prevention Policies Haven’t Slowed the Deaths

KFF Health News Original

Despite years of national strategies to address the suicide crisis in the U.S., rates continue to rise. A chorus of researchers and experts say the interventions will work — but that they’re simply not being adopted by state and local governments.

Forget Repeal and Replace. The Next Big ACA Fight Will Be Over Subsidies.

KFF Health News Original

Forget repeal and replace. Critics of the Affordable Care Act, a.k.a. Obamacare, have a new target: key parts of the law that they say are too costly and provide incentive for fraud. Topping that list are the ACA’s enhanced subsidies, put in place during the coronavirus pandemic as part of economic recovery legislation and set to […]

US Uninsured Rate Was Stable in 2023, Even as States’ Medicaid Purge Began

KFF Health News Original

About 8% of Americans lacked health insurance in 2023, the Census Bureau announced. But its report doesn’t capture the effect of states winnowing their Medicaid rolls by millions of people since the pandemic emergency ended.

Harris and Trump Are Ready To Take on Big Pharma

KFF Health News Original

Former president Donald Trump and Vice President Kamala Harris are both eager to take on high drug prices, leaving pharmaceutical companies on the defensive as they spend millions of dollars this election season. When Harris was California’s attorney general, she joined cases that resulted in almost $7.2 billion (about $22 per person in the United […]

ACA Enrollment Platforms Suspended Over Alleged Foreign Access to Consumer Data

KFF Health News Original

Federal regulators provided more specifics about why they suspended two private sector Affordable Care Act enrollment sites, including concerns about potential overseas accessing of consumer data and suspicions of involvement in Obamacare enrollment and switching schemes. The companies reject the assertions.

With TV Drug Ads, What You See Is Not Necessarily What You Get

KFF Health News Original

The pharmaceutical industry has invented a new art form: finding ways to make their wares seem like joyous must-have treatments, while often minimizing lackluster efficacy and risks.

Patients Suffer When Indian Health Service Doesn’t Pay for Outside Care

KFF Health News Original

The Indian Health Service has a program that can pay for outside appointments when patients need care not offered at agency-funded sites. Critics say money shortages, complex rules, and administrative fumbles often block access, however.

Boom, Now Bust: Budget Cuts and Layoffs Take Hold in Public Health

KFF Health News Original

State leaders are cutting public health spending and laying off workers hired during a pandemic-era grant boom. Public health officials say the bust will erode important advancements in the public health safety net, particularly in rural areas.

Del auge a la caída: falta de dinero y despidos golpean a la salud pública

KFF Health News Original

Ante la pandemia, el Congreso asignó más de $800 mil millones para fortalecer la respuesta de los estados ante covid. Esto resultó en un notable aumento del número de trabajadores de salud pública en todo el país. Ese dinero se ha esfumado.

Tribal Health Officials ‘Blinded’ by Lack of Data

KFF Health News Original

A strong public health system can make a big difference for those who face stark health disparities. But epidemiologists serving Native American communities, which have some of the nation’s most profound health inequities, say they’re hobbled by state and federal agencies restricting their access to important data. American Indians and Alaska Natives face life expectancy […]

An Arm and a Leg: Don’t Get ‘Bullied’ Into Paying What You Don’t Owe

Podcast

In this episode of “An Arm and a Leg,” host Dan Weissmann speaks with Caitlyn Mai, a woman in Oklahoma who received a six-figure bill for a surgery her insurance promised to cover. This episode is an extended version of the “Bill of the Month” series, produced in partnership with NPR.

For Pharma, Trump vs. Harris Is a Showdown Between Two Industry Foes

KFF Health News Original

Vice President Kamala Harris is seen as more aggressive than former President Donald Trump in taking on pharmaceutical companies, but Trump allies say he would also make lowering drug costs a top priority.